Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Senators Sanders and Paul Try to Sneak in Drug Reimportation Amendment

Posted on June 17, 2022 by Devon Herrick

Drug reimportation is an attractive idea until you think it though. Importing drugs from abroad would seem to make sense in a global economy. Proponents point to the fact that the United States pays the highest price for drugs of any developed country. U.S. prices are far more than developing countries pay. Opponents correctly point out what you’re importing is other countries’ price controls.

Now an unlikely bipartisan collaboration between Senators Berny Sanders and Rand Paul are trying to attach an amendment to a U.S. Food and Drug Administration user-fee program authorization to allow immediate reimportation from UK and Canada, and other European countries two years later. This from Senator Sanders:

“We have talked about reimportation for a zillion years,” said a visibly heated Sanders. “This bill actually does it. It doesn’t wait for somebody in the bureaucracy to make it happen. It actually makes it happen.” He then went on for several minutes, his tone escalating, citing statistics about high drug prices, recounting anecdotes of people who traveled for drugs, and ending with outrage about pharmaceutical companies’ campaign contributions and the number of lobbyists the industry has.

Then Senator Rand Paul chimed in:

“I always wanted to go to a Bernie rally, and now I feel like I’ve been there,” Paul joked after Sanders finished talking. He went on to offer his support for the Vermont senator’s amendment — a rare bipartisan alliance between senators who are on opposite ends of the political spectrum.

What pundits and proponents of reimporting drugs from abroad don’t understand is the price would hardly change if companies could import drugs sold abroad under a system of price controls. Rather than give up U.S. drug profits drug makers would merely raise the world price of drugs to U.S. levels and decline to sell cheaper versions to countries like the UK, Canada and others in Europe. If drug makers declined to sell drugs at low prices there is always the possibility foreign governments would pass laws allowing forced licensure and make their own version.

Join the conversation. Cancel reply

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 9 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom